Lucile P A Neyton1,2, Xiaozhong Zheng1, Christos Skouras3, Andrea Doeschl-Wilson2, Michael U Gutmann4, Iain Uings5, Francesco V Rao6, Armel Nicolas6, Craig Marshall7, Lisa-Marie Wilson7, J Kenneth Baillie2, Damian J Mole1,3. 1. Medical Research Council Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK. 2. Division of Genetics and Genomics, The Roslin Institute, The University of Edinburgh, Edinburgh, UK. 3. Clinical Surgery, School of Clinical Sciences and Community Health, The University of Edinburgh, Edinburgh, UK. 4. School of Informatics, The University of Edinburgh, Edinburgh, UK. 5. GSK Discovery Partnerships with Academia, Exploratory Discovery, Future Pipeline Discovery, Medicines Research Centre, Stevenage, UK. 6. DC Biosciences Limited, James Lindsay Place, Dundee Technopole, Dundee, UK. 7. Department of Laboratory Medicine, NHS Lothian, Edinburgh, UK.
Abstract
OBJECTIVE: Acute Pancreatitis (AP) is sudden onset pancreas inflammation that causes systemic injury with a wide and markedly heterogeneous range of clinical consequences. Here, we hypothesized that this observed clinical diversity corresponds to diversity in molecular subtypes that can be identified in clinical and multiomics data. SUMMARY BACKGROUND DATA: Observational cohort study. n = 57 for the discovery cohort (clinical, transcriptomics, proteomics, and metabolomics data) and n = 312 for the validation cohort (clinical and metabolomics data). METHODS: We integrated coincident transcriptomics, proteomics, and metabolomics data at serial time points between admission to hospital and up to 48 hours after recruitment from a cohort of patients presenting with acute pancreatitis. We systematically evaluated 4 different metrics for patient similarity using unbiased mathematical, biological, and clinical measures of internal and external validity.We next compared the AP molecular endotypes with previous descriptions of endotypes in a critically ill population with acute respiratory distress syndrome (ARDS). RESULTS: Our results identify 4 distinct and stable AP molecular endotypes. We validated our findings in a second independent cohort of patients with AP.We observed that 2 endotypes in AP recapitulate disease endotypes previously reported in ARDS. CONCLUSIONS: Our results show that molecular endotypes exist in AP and reflect biological patterns that are also present in ARDS, suggesting that generalizable patterns exist in diverse presentations of critical illness.
OBJECTIVE: Acute Pancreatitis (AP) is sudden onset pancreas inflammation that causes systemic injury with a wide and markedly heterogeneous range of clinical consequences. Here, we hypothesized that this observed clinical diversity corresponds to diversity in molecular subtypes that can be identified in clinical and multiomics data. SUMMARY BACKGROUND DATA: Observational cohort study. n = 57 for the discovery cohort (clinical, transcriptomics, proteomics, and metabolomics data) and n = 312 for the validation cohort (clinical and metabolomics data). METHODS: We integrated coincident transcriptomics, proteomics, and metabolomics data at serial time points between admission to hospital and up to 48 hours after recruitment from a cohort of patients presenting with acute pancreatitis. We systematically evaluated 4 different metrics for patient similarity using unbiased mathematical, biological, and clinical measures of internal and external validity.We next compared the AP molecular endotypes with previous descriptions of endotypes in a critically ill population with acute respiratory distress syndrome (ARDS). RESULTS: Our results identify 4 distinct and stable AP molecular endotypes. We validated our findings in a second independent cohort of patients with AP.We observed that 2 endotypes in AP recapitulate disease endotypes previously reported in ARDS. CONCLUSIONS: Our results show that molecular endotypes exist in AP and reflect biological patterns that are also present in ARDS, suggesting that generalizable patterns exist in diverse presentations of critical illness.
Authors: David M Maslove; Benjamin Tang; Manu Shankar-Hari; Patrick R Lawler; Derek C Angus; J Kenneth Baillie; Rebecca M Baron; Michael Bauer; Timothy G Buchman; Carolyn S Calfee; Claudia C Dos Santos; Evangelos J Giamarellos-Bourboulis; Anthony C Gordon; John A Kellum; Julian C Knight; Aleksandra Leligdowicz; Daniel F McAuley; Anthony S McLean; David K Menon; Nuala J Meyer; Lyle L Moldawer; Kiran Reddy; John P Reilly; James A Russell; Jonathan E Sevransky; Christopher W Seymour; Nathan I Shapiro; Mervyn Singer; Charlotte Summers; Timothy E Sweeney; B Taylor Thompson; Tom van der Poll; Balasubramanian Venkatesh; Keith R Walley; Timothy S Walsh; Lorraine B Ware; Hector R Wong; Zsolt E Zador; John C Marshall Journal: Nat Med Date: 2022-06-17 Impact factor: 87.241
Authors: Jonathan E Millar; Lucile Neyton; Sohan Seth; Jake Dunning; Laura Merson; Srinivas Murthy; Clark D Russell; Sean Keating; Maaike Swets; Carole H Sudre; Timothy D Spector; Sebastien Ourselin; Claire J Steves; Jonathan Wolf; Annemarie B Docherty; Ewen M Harrison; Peter J M Openshaw; Malcolm G Semple; J Kenneth Baillie Journal: Sci Rep Date: 2022-04-27 Impact factor: 4.996
Authors: Na Shi; Lan Lan; Jiawei Luo; Ping Zhu; Thomas R W Ward; Peter Szatmary; Robert Sutton; Wei Huang; John A Windsor; Xiaobo Zhou; Qing Xia Journal: J Pers Med Date: 2022-04-11
Authors: Ahmed E Sherif; Rory McFadyen; Julia Boyd; Chiara Ventre; Margaret Glenwright; Kim Walker; Xiaozhong Zheng; Audrey White; Laura McFadyen; Emma Connon; Dimitrios Damaskos; Michelle Steven; Anthony Wackett; Euan Thomson; David C Cameron; Jill MacLeod; Shaun Baxter; Scott Semple; David Morris; Saskia Clark-Stewart; Catriona Graham; Damian J Mole Journal: BMJ Open Date: 2020-12-07 Impact factor: 2.692